![149856-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-08/149856-Thumbnail%20Image.png?versionId=WtU2R4ux2OmJmu7zhU56SKCqweNUe8b3&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240530/us-west-2/s3/aws4_request&X-Amz-Date=20240530T153810Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=38e546c43a2d6b889c51604533e8cdd9ff51e00aa7bae2856cf2c95580cc6d8a&itok=1Hec-1pA)
![136398-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136398-Thumbnail%20Image.png?versionId=7BjzjwtlfxDXUt04AhBI30Aj45t2tsqq&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240611/us-west-2/s3/aws4_request&X-Amz-Date=20240611T124613Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=e654d7823697b8d13a08bfe1b7db1a2b2a2b973099560f8cf27fb80a4496934c&itok=pFS_ZiUn)
![136401-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136401-Thumbnail%20Image.png?versionId=k8PntGc4N.6PomUIoeBc3S8QjEG2D870&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240617/us-west-2/s3/aws4_request&X-Amz-Date=20240617T070133Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=1bfa33acf6c63315b620b26e28abcab6c6c2d79f0ee67259bb7b0c2d217e48e6&itok=Zs6CHno0)
![151493-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/151493-Thumbnail%20Image.png?versionId=EeaxH0TOuWHuJ.MEZYTw6cqou2oNXagC&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240603/us-west-2/s3/aws4_request&X-Amz-Date=20240603T124717Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=a7c2b9d49f92fedb1daf58e024a3da4b6ba624f4b998c3ae320307d07a7a08d4&itok=4bP9wY0D)
![151229-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-09/151229-Thumbnail%20Image.png?versionId=8UzPssXyrsIjM.8NWoHuBxamLElebgGA&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240618/us-west-2/s3/aws4_request&X-Amz-Date=20240618T010452Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=d5315f863705734a4e44ce32116e180fef81b3c7f8f2082e06c279379194a903&itok=XpZjsLF-)
![148322-Thumbnail Image.png](/s3/files/styles/width_400/public/2021-07/148322-Thumbnail%20Image.png?itok=QWmIoEsJ)
The field of biomedical research relies on the knowledge of binding interactions between various proteins of interest to create novel molecular targets for therapeutic purposes. While many of these interactions remain a mystery, knowledge of these properties and interactions could have significant medical applications in terms of understanding cell signaling and immunological defenses. Furthermore, there is evidence that machine learning and peptide microarrays can be used to make reliable predictions of where proteins could interact with each other without the definitive knowledge of the interactions. In this case, a neural network was used to predict the unknown binding interactions of TNFR2 onto LT-ɑ and TRAF2, and PD-L1 onto CD80, based off of the binding data from a sampling of protein-peptide interactions on a microarray. The accuracy and reliability of these predictions would rely on future research to confirm the interactions of these proteins, but the knowledge from these methods and predictions could have a future impact with regards to rational and structure-based drug design.
![136100-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136100-Thumbnail%20Image.png?versionId=sy5Wvd6f9JI9p6nVnQYcNieUJ2DXXRsZ&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240530/us-west-2/s3/aws4_request&X-Amz-Date=20240530T153906Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=b7a44e126c110dbc9ad12071e9b15cc19a7077e389a5cb9ffea9c6da8ddf7916&itok=lbCdMeJx)
![136113-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136113-Thumbnail%20Image.png?versionId=MXnBAjXixht48u0uQJGjNnMWrrl9rLGi&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240617/us-west-2/s3/aws4_request&X-Amz-Date=20240617T155109Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=e8634a5b2c7025f63f1aa7f4d80612709049e4245210d46ad2597e41dab45762&itok=eYZgoD0U)
Asymmetry scores were calculated for all three exercises. The exercise that produced the greatest absolute, average asymmetry score was the ab-slide using the roller device. The muscle that the greatest absolute asymmetry was found was the internal oblique. This means that during the three exercises and MVC, the greatest difference between right and left side pair muscles was observed in the internal obliques. The standard deviation of symmetry scores for all exercises and muscles was great as there was much variation in the skill levels in the participants of this study. Bilateral asymmetry was found by visually comparing the asymmetry scores. In conclusion, bilateral asymmetry was found in the core muscles of college-aged individuals during bilateral abdominal exercises.
![136554-Thumbnail Image.png](/s3/files/styles/width_400/public/2021-05/136554-Thumbnail%20Image.png?itok=5I3a5Jo9)
![136555-Thumbnail Image.png](https://d1rbsgppyrdqq4.cloudfront.net/s3fs-public/styles/width_400/public/2021-05/136555-Thumbnail%20Image.png?versionId=jIJR0LgUdgE7BdCGirGOC0oDCGYpZCqX&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIASBVQ3ZQ42ZLA5CUJ/20240617/us-west-2/s3/aws4_request&X-Amz-Date=20240617T085521Z&X-Amz-SignedHeaders=host&X-Amz-Expires=120&X-Amz-Signature=9a2fce2bcafac9013b26243ececf98e2d37d748fdeb22061ebde34df9c5869ab&itok=8JRLmHgT)